Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
Highlighted publications
←
→
Metabolomic profiles predict individual multidisease outcomes
Buergel et al., Nat Med., 2022
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Julkunen et al., Nat Commun., 2023
Genome-wide characterization of circulating metabolic biomarkers
Karjalainen et al., Nature, 2024
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
Medicines & trials
Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome
A. Nummela et. al, European Journal of Anaesthesiology, 2021
Obesity & bodyweight
Mitochondrial bioenergetic pathways in blood leukocyte transcriptome decrease after intensive weight loss but are rescued following weight regain in female physique athletes
H. Sarin et. al, The FASEB Journal, 2021
Genetics, Methods
A Computationally Efficient Bayesian Seemingly Unrelated Regressions Model for High-Dimensional Quantitative Trait Loci Discovery
L. Bottolo et. al, Journal of the Royal Statistical Society Series C: Applied Statistics, 2021
Exposome & nutrition
NMR Metabolite Profiles in Male Meat-Eaters, Fish-Eaters, Vegetarians and Vegans, and Comparison with MS Metabolite Profiles
J. Schmidt et. al, Metabolites, 2021
A. Nag et. al, 2021
Diabetes, Risk prediction
Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study
F. Bragg et. al, BMC Medicine, 2022
Inflammation & immunity
Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk
G. Robinson et. al, Metabolites, 2021
Cardiovascular disease
Metabolic Biomarker Discovery for Risk of Peripheral Artery Disease Compared With Coronary Artery Disease: Lipoprotein and Metabolite Profiling of 31 657 Individuals From 5 Prospective Cohorts
E. Tikkanen et. al, Journal of the American Heart Association, 2021
Maternal & child health
Evaluating the direct effects of childhood adiposity on adult systemic metabolism: a multivariable Mendelian randomization analysis
T. Richardson et. al, International Journal of Epidemiology, 2021
Ageing & dementia
Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s disease
J. Lord et. al, Proceedings of the National Academy of Sciences, 2021
S. Fang et. al, 2021
Cardiovascular disease
Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study
M. Johansen et. al, Clinical Chemistry, 2020
Cardiovascular disease
Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood
X. Ojanen et. al, eBioMedicine, 2021
Cardiovascular disease
The associations of oxidized lipoprotein lipids with lipoprotein subclass particle concentrations and their lipid compositions. The Cardiovascular Risk in Young Finns Study
P. Kresanov et. al, Free Radical Biology and Medicine, 2020